Sylvia Cheung

Sylvia Cheung is the Chief Financial Officer at Anika Therapeutics since April 1, 2013. Sylvia brings to Anika a substantial number of years of financial and general management experience. Prior to her current position, Sylvia was the Vice President of Strategic Processes and previously, she served as the General Manager for the company’s Italian-based subsidiary, Anika S.r.l. Sylvia joined Anika as Controller in 2005. In addition to fulfilling wide-ranging financial responsibilities as Controller, Sylvia led the company’s integration of Anika S.r.l. subsequent to its acquisition in 2009.

Prior to Anika, she held a series of progressively responsible financial management positions at Transkaryotic Therapies, Inc.

From 1995 to 2000, Sylvia worked for PricewaterhouseCoopers, LLP as an Audit Senior Associate.

Sylvia holds a Bachelor of Business Administration degree in Accounting from the University of Massachusetts in Amherst, a Master’s degree in Business Administration from Boston University, and is a Certified Public Accountant (inactive).

Sylvia Cheung is the Chief Financial Officer at Oculis, based in United States, North America. With a background in Biotechnology, Sylvia Cheung has a rich history of leadership and innovation.Sylvia Cheung studied MBA unknown at Boston University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.